This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background Heartfailure with preserved ejection fraction is a recognised outcome in patients with myocardial infarction, although heartfailure with reduced ejection fraction is more common. fold higher risk of heartfailure with preserved ejection fraction (95% CI 1.30 m/s had a 2.10-fold
Demographic, clinical, and diagnostic data, as well as follow-up outcomes, were reviewed. Logistic and Cox regression models identified riskfactors for in-hospital and long-term mortality.ResultsAmong the 212 patients, 79.72% (169/212) had HCM, 16.98% (36/212) had RCM, and 3.30% (7/212) had RP-HCM.
Association of clonal haematopoiesis with heartfailure incidence and outcomes: A systematic review and meta-analysis. Clonal haematopoiesis and heartfailure: a meta-analysis. CH, clonal haematopoiesis; CI, confidence interval; HF, heartfailure.
Background We evaluated the potential of circulating bone morphogenetic protein 10 (BMP10) as a biomarker for atrial stress and remodelling in patients with heartfailure (HF), in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP). We also assessed the predictive value of BMP10 for adverse clinical outcomes.
Heartfailure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. 2 Therefore, early identification of HF in high-risk populations, particularly post-MI, is essential for improving outcomes.
Getty Images mtaschetta-millane Tue, 07/09/2024 - 07:23 July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet nearly half of U.S. and those in the South had the highest cardiovascular risk index. counties do not have a practicing cardiologist. miles vs 87.1
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
BackgroundInfective endocarditis (IE) is still a fatal disease, and given its rarity, ongoing updates to patient characteristics and outcomes of IE are essential for providing precision diagnoses and effective treatments. The inhospital mortality rate was 14.5%, which significantly increased from 14.1% in 2016 to 15.4%
Background and aims Pre-eclampsia complicates 3–5% of pregnancies worldwide and is associated with adverse outcomes for the mother and the offspring. Pre-eclampsia and heartfailure have common riskfactors, including hypertension, obesity and diabetes.
Life-threatening complications of infective endocarditis (IE,) are heartfailure, uncontrolled infection and embolic events (EE), which pose significant morbidity and mortality risks.
1 This trend—which is also anticipated internationally—underpins efforts to identify individuals at high risk of future AF, in addition to those with AF without manifest symptoms, in the hope of targeted prevention and early treatment. Recent estimates suggest that AF accounts for between 0.9% 2 Before the.
IntroductionDepression is a significant comorbidity linked to poor subjective and objective health outcomes in cardiac patients. In addition, three studies found that age and female gender were significant riskfactors in depressed patients. Approximately, 31.3% (n=1,264) cardiac patients were depressed.
Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share riskfactors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.
Proposed approach for clinical management and therapeutic optimization in patients with heartfailure with reduced ejection fraction and low blood pressure. This clinical consensus statement provides a comprehensive overview of low BP in HFrEF, including its definition, riskfactors, and effects of HF therapies on BP.
Obesity is common in the heartfailure (HF) population and is regarded as an important riskfactor for developing HF. Greater skeletal muscle mass has shown to be the underlying protective factor against cardi.
Its effects on the heart are particularly alarming, as smoking significantly increases the risk of cardiovascular diseases (CVDs) and complicates medical procedures such as minimally invasive or bloodless heart surgeries. Reduced Long-Term Success Rates For smokers, the long-term success of heart surgeries is often diminished.
Abstract Diagnosing heartfailure is often difficult due to the non-specific nature of symptoms, which can be caused by a range of medical conditions. Natriuretic peptides (NPs) have been recognized as important biomarkers for diagnosing heartfailure. Use of this acronym would enable the early diagnosis of heartfailure.
Background:Stage B heartfailure (HF) was associated with increased cardiovascular and HF events. Hypertension is a riskfactor for these events in Stage B HF. Conclusions:Elevated nighttime home BP was a significant predictor for cardiovascular outcomes in stage B HF patients. 3.65, p=0.02).Conclusions:Elevated
Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heartfailure, as well as among adults with few cardiovascular riskfactors.
Heartfailure (HF) is a global public health concern that affects millions of people worldwide. While there have been significant therapeutic advancements in HF over the last few decades, there remain major disparities in riskfactors, treatment patterns and outcomes across race, ethnicity, socioeconomic status, country and region.
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 trillion by 2050, according to two American Heart Association ( AHA ) presidential advisories published June 4 in the AHA journal Circulation.
Atrial fibrillation (AFib) is a common heart rhythm disorder characterized by an irregular and often rapid heartbeat. This condition can lead to various complications, including stroke and heartfailure, making it essential to understand its causes, symptoms, and AFib treatment options.
fold increased mortality risk compared to lowest quartile. fold increase in 3-year HF hospitalization or all-cause mortality risk (adjusted HR [95%CI] for Q4vQ1: 1.94 [1.14-3.28]). Conclusion High levels of PAGln are associated with adverse outcomes independent of traditional cardiac riskfactors and cardio-renal risk markers.
Abstract Aim To examine the ability of serum proteins in predicting future heartfailure (HF) events, including HF with reduced or preserved ejection fraction (HFrEF or HFpEF), in relation to event time, and with or without considering established HF-associated clinical variables. for all incident HF, 0.78
Research covered topics such as outcomes for pediatric subcutaneous ICD implantation; procedural success rates and riskfactors associated with catheter ablation for atrial tachyarrhythmias; comparing echocardiographic guidance during left atrial appendage occlusion (LAAO); and atrial fibrillation (AFib) ablation in patients with heartfailure with (..)
Background:The prevalence of riskfactors for heartfailure and outcomes varies across racial and ethnic groups. Despite this variation, treatment guidelines for heartfailure are standardized, potentially overlooking the unique needs and responses of minority populations.
BackgroundPrior studies investigating the impact of residual mitral regurgitation (MR), tricuspid regurgitation (TR), and elevated predischarge transmitral mean pressure gradient (TMPG) on outcomes after mitral transcatheter edge‐to‐edge repair (TEER) have assessed each parameter in isolation. Overall, mean age was 76.7±10.6
The primary outcome was a composite of inhospital adverse events. Associations between multimorbidity patterns and outcomes were evaluated using multivariableadjusted logistic regression models. years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Among 9570 patients, 50% (n=4789) had multimorbidity.
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular riskfactors: heartfailure, diabetes, atrial fibrillation, dyslipidemia and hypertension.
BACKGROUND:Diabetes is an important riskfactor for heartfailure (HF) and is associated with left ventricular (LV) diastolic dysfunction. 11.57];P=0.014) patterns were associated with elevated risk of the outcome of LV diastolic dysfunction. Hypertension, Ahead of Print.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
2, 2024 — Eko Health recently announced a new independent study from researchers at Imperial College London (Imperial) that demonstrated how AI can identify patients with significantly higher risk of experiencing major adverse cardiac events (MACE), including heart attacks and heartfailure. Nicholas S.
Hypertension is the single most important riskfactor for development of atrial fibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heartfailure and stroke.
fold higher risk for cardiac mortality and 5.5-fold fold higher risk for major adverse cardiac events (MACE) Caristo's AI-Risk model, CaRi-HeartRisk Score, outperformed other scores in routine clinical use for prediction of cardiac mortality, and when presented to clinicians, resulted in changes of management decision in 45% of the patients.
Diabetes is a riskfactor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. IntroductionThere is a higher prevalence of diabetes mellitus type 2 in Hispanics as compared to other ethnic groups in the United States. or greater. vs. 20.5%; p = 0.048) and stenting (28.4%
This year’s theme, “Advancing Cardiovascular Care for All” brings the latest practice-changing breakthroughs, along with top experts debating and discussing outcomes of highly-anticipated clinical trials. 24 from April 6 - 8, 2024 in Atlanta, GA at the Georgia World Congress Center.
Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heartfailure and myocardial infarction. Hospitalisation due to this condition is exponentially growing, and now outnumbers those for both heartfailure and myocardial infarction.
This miscommunication can cause blood to pool in the atria, increasing the risk of clot formation, which can then lead to strokes. AFib is associated with a fivefold increased risk of stroke, and it is also linked to heartfailure, chronic fatigue, and other serious health issues. www.adncoe.com
Socioeconomic status (SES) is a well-validated riskfactor for poor outcomes among patients with heartfailure, but its influence on adverse events in patients post-LVAD is poorly understood and may be overestimated. Further studies are necessary to evaluate if DCI impacts other adverse outcomes post LVAD.
This miscommunication can cause blood to pool in the atria, increasing the risk of clot formation, which can then lead to strokes. AFib is associated with a fivefold increased risk of stroke, and it is also linked to heartfailure, chronic fatigue, and other serious health issues. www.adncoe.com
If untreated, AFib can lead to or exacerbate heartfailure, and it significantly increases a person’s risk of stroke. Catheter ablation was given the highest Class 1 treatment recommendation for appropriately selected patients, including those with heartfailure with reduced ejection fraction.
These conditions often intersect, sharing common riskfactors and underlying mechanisms. This discussion explores the principles and practices of evidence-based cardiometabolic medicine, emphasizing the importance of integrating the latest research findings into clinical decision-making to improve patient outcomes.
Complications can occur during each phase, with long-term survivors facing increased risks for late effects such as cardiovascular disease, secondary malignancies, and endocrinopathies. Acute heartfailure has an incidence ranging from 0.4%
Studies have reported racial disparities in young stroke patients and less desired outcomes of minorities. Socioeconomic status, riskfactors, stroke etiology, acute interventions and short-term outcomes were accessed. Introduction:A rising prevalence of stroke in young patients was noticed in recent years.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content